v2.2
Contact
News
Diagnosing DIRD
Browse
Available on AppStore
The Drug-Induced Respiratory Disease Website
Philippe Camus, M.D.
Dijon, France
Browse by »
Drugs
Patterns
Chemotherapy, antineoplastic
5
VI.c
Pulmonary veno-occlusive disease
1
Last update :
31/08/2012
Search
Search
Identify causative drugs
Diagnosing DIRD
1
Drug and radiation history
2
Drug singularity - Correct identification of the drug
3
Consistent timing of exposure v. onset of symptoms
4
Clinical, imaging, BAL, pathological pattern consistent with the specific drug
5
Careful exlusion of another cause
6
Remission of symptoms with removal of drug
7
Recurrence with rechallenge (rarely advisable)
8
Causality assessment
More detailed checklist
See also under
Amrubicin
Anthracyclines
Azacitidine
Bendamustine
Bleomycin
Bortezomib
Busulfan
Capecitabine
Carboplatin
Carmustine (BCNU)
Cetuximab
Chlorozotocin (DCNU)
Cisplatin
Crizotinib
Cyclophosphamide
Cytosine arabinoside - Aracytine - Cytarabine - Ara-C
Decitabine
Docetaxel
Doxorubicin - Adriamycin
Erlotinib
Etoposide
FOLFIRI chemotherapy regimen
FOLFOX chemotherapy regimen
Famotidine
Floxuridine
Fludarabine
Fluorouracil (5-FU)
Fotemustine
Gefitinib
Gemcitabine
Gemtuzumab
Hydroxyurea (hydroxycarbamide)
Ifosfamide
Immune checkpoint inhibitors (ICI) - ICI combinatorial Rx
Irinotecan
Lomustine (CCNU)
Melphalan
Methotrexate
Mitomycin C
Mitoxantrone
Nitrogen mustard
Nitrosoureas (suffixes '-NU', '-mustine')
Oxaliplatin-based regimens
Paclitaxel
Pemetrexed
Platinum salts
Procarbazine
Raltitrexed
Taxanes
Temozolomide
Teniposide
Topotecan
Trofosfamide
Tyrosine kinase inhibitors (EGFR) TKI
Vinblastine
Vindesine
Vinorelbine
Zinostatin
Publications
Chemotherapy-induced pulmonary hypertension: role of alkylating agents.
Pulmonary veno-occlusive disease: an 80-year-old mystery.
Fatal pulmonary veno-occlusive disease after chemotherapy for Burkitt's lymphoma.
Pulmonary veno-occlusive disease after chemotherapy.